MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells

Prostate cancer is the most commonly diagnosed cancer in men with African American men disproportionally suffering from the burden of this disease. Biomarkers that could discriminate indolent from aggressive and drug resistance disease are lacking. MicroRNAs are small non-coding RNAs that affect num...

Descripción completa

Detalles Bibliográficos
Autores principales: Cagle, Patrice, Niture, Suryakant, Srivastava, Anvesha, Ramalinga, Malathi, Aqeel, Rasha, Rios-Colon, Leslimar, Chimeh, Uchechukwu, Suy, Simeng, Collins, Sean P., Dahiya, Rajvir, Kumar, Deepak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611815/
https://www.ncbi.nlm.nih.gov/pubmed/31278310
http://dx.doi.org/10.1038/s41598-019-46170-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611815/
https://www.ncbi.nlm.nih.gov/pubmed/31278310
http://dx.doi.org/10.1038/s41598-019-46170-3

Ejemplares similares